State of Alaska
Department of Health

Division of Health Care Services

The Division will be sponsoring the following meeting to address the Drug Utilization Review. 

Please note, this meeting will be available via teleconference only.

Please register for the meeting by using the link below:

https://events.teams.microsoft.com/event/bc8ebd19-b170-4d9c-807b-6dd4f1d5e7a6@34c95ba7-5ec6-4527-bc5e-b33b58104992

After registering, you will receive a confirmation email containing information about joining the webinar.

The Drug Utilization Review Committee will meet Friday, January 17, 2025 at 1:00 p.m. Agendas are posted on the Health Care Services Drug Utilization website https://health.alaska.gov/dhcs/Pages/pdl/drugutilizb_pdl.aspx. If you would like to join via teleconference, please dial 1-844-730-9010. Webinar ID: 776 394 641#

Any pharmaceutical manufacturer may submit unsolicited material related to the agenda items by utilizing the Clinical Submission form. Clinical Submissions will be accepted until January 3, 2025 at 4:00pm AK local time. Forms may be found at: https://health.alaska.gov/dhcs/Pages/pdl/download_pdl.aspx.

Any member of the public, including health care professionals, may submit unsolicited material related to the agenda items by sending an email to matthew.parrott@alaska.gov or via mail to 4601 Business Park Blvd, Bldg K, Anchorage, AK 99503. A conflict of interest form must accompany any submission and can be found at:  https://health.alaska.gov/dhcs/Documents/pharmacy/forms/Alaska-Medicaid-Clinical-Coverage-Review-Request-Disclosure-Form.pdf. Submissions should be received no later than January 15, 2025 to allow inclusion in the meeting. If you cannot join the webinar and would like to join via teleconference, please dial toll free 1-844-730-9010 Webinar ID: 776 394 641#.